dobutamine has been researched along with glucagon in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (60.00) | 18.7374 |
1990's | 4 (26.67) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeWood, MA; Spores, J | 1 |
Benvenisty, AI; Hoffman, BF; Malm, JR; Rose, EA; Spotnitz, HM | 1 |
Argenta, LC; Baker, R; Bove, EL; Cimmino, VM; Kirsh, MM; Lee, R; Lucchesi, B; Sloan, H; Straker, J | 1 |
Foldenauer, A; Keck, FS; Pfeiffer, EF; Wolf, CF; Zeller, G | 1 |
Braunwald, E; Colucci, WS; Wright, RF | 1 |
Talesnik, J; Youngson, BJ | 1 |
Segel, LD | 1 |
Nadeau, A; Nadeau, S; Rousseau-Migneron, S | 1 |
Herbert, P; Tinker, J | 1 |
Bardet, J; Bourdarias, JP; Dubourg, O; Ferrier, A; Gueret, P | 1 |
Hartikainen, J; Parviainen, M; Takala, J; Uusaro, A | 1 |
Doyon, S; Roberts, JR | 1 |
Crooks, BN; Deshpande, SA; Hall, C; Milligan, DW; Platt, MP | 1 |
Ahlberg, AW; Heller, GV; Katten, D; Murthy, DR; Salloum, A; White, CM | 1 |
Hernández, J; Juan-Fita, MJ; Vargas, ML | 1 |
3 review(s) available for dobutamine and glucagon
Article | Year |
---|---|
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Calcium; Cardiotonic Agents; Cyclic AMP; Dobutamine; Dopamine; Drug Tolerance; Glucagon; Heart Failure; Histamine; Humans; Levodopa; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Receptors, Adrenergic; Receptors, Adrenergic, beta; Stimulation, Chemical; Sympathomimetics; Theophylline; Xanthines | 1986 |
Inotropic drugs in acute circulatory failure.
Topics: Adrenergic alpha-Agonists; Albuterol; Animals; Cardiotonic Agents; Catecholamines; Digitalis Glycosides; Dobutamine; Glucagon; Humans; Shock | 1980 |
Inotropic agents in the treatment of cardiogenic shock.
Topics: Cardiac Output, Low; Cardiac Tamponade; Cardiotonic Agents; Catecholamines; Digitalis; Dobutamine; Dopamine; Glucagon; Humans; Isoproterenol; Metaraminol; Methoxamine; Myocardial Infarction; Norepinephrine; Phenylephrine; Plants, Medicinal; Plants, Toxic; Pulmonary Embolism; Shock, Cardiogenic | 1983 |
1 trial(s) available for dobutamine and glucagon
Article | Year |
---|---|
Effect of intravenous metoprolol or intravenous metoprolol plus glucagon on dobutamine-induced myocardial ischemia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Dobutamine; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Glucagon; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Metoprolol; Middle Aged; Myocardial Ischemia; Protein Synthesis Inhibitors; Tomography, Emission-Computed, Single-Photon | 2000 |
11 other study(ies) available for dobutamine and glucagon
Article | Year |
---|---|
Clinical use of inotropic agents.
Topics: Cardiac Output; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Epinephrine; Glucagon; Humans; Isoproterenol; Norepinephrine | 1979 |
Antagonism of chronic canine beta-adrenergic blockade with dopamine-isoproterenol, dobutamine, and glucagon.
Topics: Animals; Cardiac Output; Catecholamines; Chronic Disease; Dobutamine; Dogs; Dopamine; Glucagon; Hemodynamics; Isoproterenol; Propranolol | 1979 |
A comparison of the hemodynamic effects of inotropic agents.
Topics: Animals; Cardiac Output; Depression, Chemical; Dobutamine; Dogs; Dopamine; Glucagon; Heart Rate; Hemodynamics; Isoproterenol; Myocardial Contraction; Nitroprusside; Norepinephrine; Pentobarbital; Phentolamine; Stimulation, Chemical; Vascular Resistance | 1976 |
Comparative effects of dopamine and dobutamine on glucoregulation in a rat model.
Topics: Animals; Blood Glucose; Dobutamine; Dopamine; Glucagon; Homeostasis; Infusions, Intravenous; Insulin; Male; Rats; Rats, Inbred Strains; Thyroidectomy | 1991 |
Modulation of positive inotropy and metabolic coronary dilatation by myocardial alpha-adrenoceptors.
Topics: Animals; Calcium Chloride; Catecholamines; Coronary Vessels; Dobutamine; Electric Stimulation; Glucagon; In Vitro Techniques; Isoproterenol; Male; Methoxamine; Muscle, Smooth, Vascular; Myocardial Contraction; Norepinephrine; Phenoxybenzamine; Phentolamine; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Tyramine; Vasodilation | 1985 |
Alcoholic cardiomyopathy in rats: inotropic responses to phenylephrine, glucagon, ouabain, and dobutamine.
Topics: Animals; Cardiomyopathy, Alcoholic; Dobutamine; Glucagon; In Vitro Techniques; Male; Myocardial Contraction; Ouabain; Oxygen Consumption; Phenylephrine; Rats; Reference Values; Stroke Volume | 1987 |
Hyperglycemic effect of high doses of dobutamine in the rat: studies of insulin and glucagon secretion.
Topics: Animals; Blood Glucose; Dobutamine; Glucagon; Hyperglycemia; Insulin; Insulin Secretion; Male; Mannitol; Rats; Rats, Inbred Strains; Time Factors | 1985 |
Metabolic stress modifies the thermogenic effect of dobutamine in man.
Topics: Adult; Dobutamine; Energy Metabolism; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glycerol; Hemodynamics; Humans; Hydrocortisone; Infusions, Intravenous; Male; Oxygen Consumption; Prospective Studies; Stress, Physiological | 1995 |
The use of glucagon in a case of calcium channel blocker overdose.
Topics: Acute Disease; Aged; Bradycardia; Dobutamine; Dopamine; Drug Overdose; Drug Therapy, Combination; Female; Glucagon; Humans; Hypotension; Shock, Cardiogenic; Verapamil | 1993 |
Adverse neonatal effects of maternal labetalol treatment.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cardiomegaly; Dobutamine; Dopamine; Drug Therapy, Combination; Fatal Outcome; Female; Glucagon; Humans; Infant, Newborn; Labetalol; Norepinephrine; Pericardial Effusion; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects | 1998 |
The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Exonucleases; Female; Glucagon; Heart Ventricles; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase I; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Quinolones; Rats; Rats, Sprague-Dawley; Ventricular Function; Xanthines | 2005 |